Thomas Bartl
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Arterial embolization for hemorrhage control in gynecologic malignancies: a narrative review of current evidence and unresolved questions.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 07, 2026
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiative.
Journal: Gynecologic oncology
Published: February 01, 2026
Targeting RAS-RAF-MEK-ERK signaling in mucinous ovarian cancer: a translational evidence synthesis and clinical framework.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 23, 2025
Therapeutic Effects of Lurbinectedin in PARP Inhibitor-Resistant High-Grade Serous Ovarian Cancer Using Patient-Derived Cell Lines and Organoid Models.
Journal: International journal of molecular sciences
Published: August 07, 2025
Novel Treatment Concepts for Cervical Cancer-Moving Towards Personalized Therapy.
Journal: Journal of personalized medicine
Published: June 21, 2025
Indocyanine green fluorescence angiography for bowel anastomosis assessment in ovarian cancer surgery.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 09, 2025
Metastasized inflammatory myofibroblastic tumor of uterine origin.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 07, 2024
Diagnostic management of endometrial cancer in a single horn of a bicornuate uterus.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 30, 2024
Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?
Journal: Cancers
Published: August 27, 2024
Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy.
Journal: Journal of gynecologic oncology
Published: August 08, 2024
The Predictive Value of the Fibrinogen-Albumin-Ratio Index on Surgical Outcomes in Patients with Advanced High-Grade Serous Ovarian Cancer.
Journal: Cancers
Published: August 07, 2024
Last Updated: 09/26/2026